57.82M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016.

Similar securities

Based on sector and market capitalization

Report issue